Detalhe da pesquisa
1.
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness.
J Transl Med
; 22(1): 35, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191367
2.
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 14(11): 1104-1111, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24035405
3.
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
Cancer Immunol Immunother
; 62(6): 1021-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591982
4.
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.
J Transl Med
; 11: 202, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23987572
5.
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
Lancet Oncol
; 13(9): 879-86, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22894884
6.
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.
J Cell Physiol
; 226(10): 2595-600, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792917
7.
"Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014.
Cancer Immunol Immunother
; 65(1): 119-26, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25944004
8.
"Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015.
Cancer Immunol Immunother
; 65(11): 1423-1431, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619513
9.
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
J Cell Physiol
; 223(2): 352-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20127705
10.
"Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013.
Cancer Immunol Immunother
; 64(1): 131-5, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24993565
11.
Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.
Cancer Immunol Res
; 7(1): 12-28, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30401679
12.
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.
Cancer Immunol Immunother
; 62(12): 1851-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190546
13.
The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.
J Transl Med
; 6: 8, 2008 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18269750
14.
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
Clin Cancer Res
; 13(11): 3333-8, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545540
15.
The Italian Network for Tumor Biotherapy (NIBIT). Sharing visions, goals and efforts at European level.
Tumori
; 94(2): 179-81, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18564604
16.
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.
Cancer Immunol Immunother
; 61(9): 1599-608, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22736255
17.
The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Clin Cancer Res
; 12(11 Pt 1): 3297-305, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16740750
18.
Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.
Cancer Immunol Immunother
; 60(6): 901-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21431916
19.
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Cancer Res
; 64(24): 9167-71, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15604288
20.
ICOS Expression as Immunologic Marker in Immune Activating Monoclonal Antibodies.
Methods Mol Biol
; 1393: 133-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27033223